The total or global diversity of the de novo designed libraries and the DNMT1 inhibitors dataset was analyzed, considering multiple structure representations. Specifically, the data sets were compared regarding structural fingerprints, molecular scaffolds, and properties of pharmaceutical interest. Considering the different representations, the total or global diversity of the data sets was analyzed using Consensus Diversity Plots (CDPlots) .